Direct medical costs associated with treatment non-persistence in patients with higher-risk myelodysplastic syndromes receiving hypomethylating agents: A large retrospective cohort analysis

Publication date: Available online 9 December 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Namita Joshi, Hrishikesh Kale, Shelby Corman, Tim Wert, Kala Hill, Amer M. Zeidan
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research